by Max Jones and Whitney Webb, Unlimited Hangout:
TRUTH LIVES on at https://sgtreport.tv/
Built on a promise to eliminate industry capture of public health regulatory agencies and curb the influence of Big Pharma and Big Food, Robert F. Kennedy Jr.’s MAHA movement played a crucial role in funneling would-be Kennedy voters into the Trump camp. MAHA, in essence, granted the Trump campaign a tinge of populist legitimacy among Covid era dissidents, which grew out of the shuttering of RFK Jr.’s independent presidential run.
However, O’Neill’s business connections, both past and present, as well as his previous statements on public health policy, strongly suggest that he is not only unlikely to implement the policies that MAHA-centric voters are expecting, but that he may in fact pursue an agenda that stands in direct conflict with the main tenets of the MAHA movement. Specifically, he advocates reforming the FDA to deregulate and accelerate the pathway from drug development to legalization. This would notably aid the biotech industry, which has long struggled to get its products approved outside of an “emergency”-based deregulatory paradigm.
When considering the investments and board positions that O’Neill himself has made and held in biotechnology companies, this would likely include mRNA products that Kennedy and other MAHA influencers have spent years criticizing since the Covid-19 pandemic — a clear contradiction between O’Neill’s views on public health, and those which the MAGA base were sold on the campaign trail.
Perhaps standing in even starker contrast with MAHA principles, O’Neill currently sits on the board of a company that is currently pursuing the development of a neurotoxic substance as a “therapeutic” treatment for people with Alzheimer’s disease (a neurodegenerative disease). Ironically, that same substance has long been flagged by Kennedy and the organization he co-founded, Children’s Health Defense, as one of the main causative agents in their hypothesis for a vaccine-autism link and other chronic conditions suffered by many Americans, particularly children.
In addition to O’Neill’s biotech connections, he also boasts significant ties to the CIA-linked company Palantir and its co-founder Peter Thiel. Palantir, notably, is undertaking considerate efforts to apply a pre-crime paradigm to public health events, mainly through its several significant contracts with HHS that would greatly determine the nature of the “public health emergency preparedness” that O’Neill will directly oversee. Several of these contracts date back to the first Trump administration, when Palantir played a major role in the military-run Covid-19 biosurveillance and vaccine development / distribution program known as Operation Warp Speed – a program that has been heavily criticized by both Kennedy and the broader MAHA movement.
Indeed, Palantir has since further entrenched its role within the HHS apparatus, most recently via the CDC’s Center for Forecasting and Outbreak Analytics (CFA), a disease forecasting and mass biosurveillance program that Palantir runs significant amounts of data for.
Also indirectly connected to this CDC effort is Bill Gates, as the former vice-president of the Gates-connected Cascade Investment firm, Dylan George, now runs the CFA. Importantly, the Gates Foundation has significant investments in biotechnology, an industry that notoriously faces strenuous regulatory difficulties in getting its products through the standard Food and Drug Administration (FDA) approval process. As a result, prominent players in the biotech industry, including Gates as well as others like Trump surrogate Vivek Ramaswamy, have embarked on an effort to dismantle the current regulatory paradigm and replace it with one friendly to “innovation,” or in other words, one with significantly less rigorous standards.
Read More @ UnlimitedHangout.com
What REALLY Happened in the Oval Office?